Insight Molecular Diagnostics Cash Flow Statement (2020-2025) | IMDX

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter) -9.92M-6.92M-6.78M-6.63M-3.92M-10.49M-13.80M-35.69M-6.88M-6.94M-7.51M-32.96M-2.93M-9.13M-4.63M-13.52M-33.63M-6.80M-9.84M-11.05M17.14M
Depreciation and Depletion (Quarter) 0.06M0.07M0.07M-0.22M0.12M0.21M0.26M0.26M0.29M0.38M0.39M0.47M0.45M0.43M0.40M
Share-based Compensation (Quarter) 0.94M1.36M1.78M0.98M1.29M2.00M1.85M1.71M2.01M2.23M3.18M2.62M0.83M0.83M0.61M0.48M0.42M0.39M0.45M0.50M0.47M0.50M0.52M0.72M
Deferred Taxes (Quarter) -1.09M-0.16M-7.56M-1.79M0.10M
Gains from Sales and Divestitures (Quarter) 0.00M0.02M
Gains from Investment Securities (Quarter) 6.42M6.83M0.14M-1.03M1.13M0.03M4.75M25.01M-4.66M-6.36M-6.14M17.26M-18.31M0.18M-0.43M11.19M7.14M0.66M2.80M0.03M-1.11M
Asset Writedowns and Impairment (Quarter) -0.33M0.33M5.00M-0.05M1.81M-0.00M36.90M
Non-cash Items (Quarter) 8.10M19.10M0.19M51.000.23M0.14M0.11M0.31M8.54M
Cash from Operations (Quarter) -6.87M-6.96M-6.00M-6.14M-9.84M-8.06M-10.98M-7.07M-13.28M-11.25M-11.40M-9.65M-8.30M-6.83M-3.77M-4.42M-3.83M-5.98M-5.53M-5.35M-5.86M-6.28M-4.50M-5.54M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.01M0.02M0.02M0.02M0.31M1.07M0.99M0.99M0.93M0.98M0.98M0.81M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.01M
Amortization of Deferred Charges (Quarter) 0.04M0.02M0.02M0.02M0.02M0.01M0.01M0.01M0.01M0.00M0.00M
Depreciation & Amortization (CF) (Quarter) 0.06M0.07M0.07M-0.22M0.12M0.21M0.26M0.22M0.29M0.38M0.39M0.40M0.45M0.43M0.40M0.30M0.31M0.30M0.32M0.54M0.48M0.56M0.58M0.56M
Change in Working Capital
Change in Receivables (Quarter) -0.01M0.09M0.29M-0.19M0.50M0.32M0.01M0.41M0.69M-0.32M0.19M0.02M-0.11M-0.18M0.17M0.02M-0.32M-0.08M0.12M1.40M1.93M-3.03M-0.25M0.87M
Change in Inventory (Quarter) 0.23M0.18M0.05M0.23M-0.22M-0.03M
Change in Account Payables (Quarter) -0.01M
Change in Accured Expenses (Quarter) 1.25M-0.18M0.78M-0.99M0.41M-1.17M-0.83M0.24M-0.02M0.26M0.18M-0.12M-2.66M-1.66M0.13M-0.56M0.85M-1.24M0.65M0.70M1.03M-3.11M1.18M3.56M
Other Working Capital Changes (Quarter) 0.91M-0.13M-0.25M0.97M1.14M-1.03M0.68M-1.01M-0.04M-0.01M-0.11M0.04M-0.03M-0.53M-0.08M0.54M-0.10M-0.03M0.48M0.08M-0.03M-0.04M-0.06M-0.02M
Investing Activities
Capital Expenditures (Quarter) 0.04M0.49M0.53M0.17M0.84M0.61M0.39M0.40M1.56M1.12M0.86M0.80M-0.56M0.26M0.02M0.19M0.09M0.21M0.31M0.35M1.05M1.48M
Sales of Property, Plant and Equipment (Quarter) 0.23M
Acquisitions (Quarter) 6.19M0.61M
Cash from Investing Activities (Quarter) -6.19M-4.53M-0.53M-0.50M-8.27M-4.89M-0.39M-0.40M-1.56M-1.12M-0.86M-0.80M-1.37M0.12M0.21M0.10M-0.02M-0.19M-0.09M-0.21M-0.31M-0.35M-1.05M-1.48M
Financing Activities
Other financing activities (Quarter) 0.00M0.03M0.03M2.68M-0.00M0.54M0.84M0.49M-0.41M
Cash from Financing Activities (Quarter) 7.57M11.71M0.03M3.49M69.87M0.55M8.21M-0.27M-0.35M36.79M-0.53M-0.10M-0.03M12.27M-0.03M-0.03M9.85M-0.26M10.84M28.56M-0.11M-0.12M-0.25M
Additional items
Exchange Rate Effect (Quarter) -0.00M-0.01M
Change in Cash (Quarter) -5.50M0.22M-6.50M-3.15M51.76M-12.40M-3.16M-7.74M-15.21M24.45M-12.78M-10.55M-9.70M5.57M-3.58M-4.35M-3.85M3.68M-5.89M5.27M22.39M-6.74M-5.78M-7.29M
Free Cash Flow (Quarter) -6.91M-7.45M-6.53M-6.31M-10.68M-8.67M-11.38M-7.47M-14.84M-12.37M-12.26M-10.45M-8.30M-6.83M-3.21M-4.69M-3.85M-6.17M-5.62M-5.57M-6.17M-6.63M-5.55M-7.02M
Net Cash Flow (Quarter) -5.50M0.22M-6.50M-3.15M51.76M-12.40M-3.16M-7.74M-15.19M24.42M-12.78M-10.55M-9.70M5.57M-3.58M-4.35M-3.85M3.68M-5.87M5.28M22.39M-6.74M-5.67M-7.28M